期刊
CHEMICAL BIOLOGY & DRUG DESIGN
卷 71, 期 4, 页码 287-297出版社
WILEY
DOI: 10.1111/j.1747-0285.2008.00640.x
关键词
antimalarial drug targets; apicoplast; cyclin-dependent kinases; malaria; parasite proteases; Plasmodium falciparum; pyruvate kinase
Malaria with one million deaths and about 500 million new cases reported annually is a challenge to drug therapy and discovery. As current antimalarial therapeutics become increasingly ineffective because of parasitic resistance, there exists an urgent need to develop and pursue new therapeutic strategies. Antimalarial drug development can follow several strategies, ranging from minor modifications of existing agents to the design of novel agents that act against new targets. Recent advances in our knowledge of parasite biology as well as the availability of the genome sequence provide a wide range of novel targets for drug design. Several promising targets for drug intervention have been revealed in recent years. This review discusses novel molecular targets of the malaria parasite available to the drug discovery scientist.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据